colchicine
Musculo-skeletal system (M04)US regulatory status: approved. Molecular target: Tubulin.
- Target
- Tubulin
- Mechanism
- Tubulin inhibitor
pharma · Irritable Bowel Syndrome With Constipation · Chronic Constipation · IRWD
IRONWOOD PHARMACEUTICALS
IRONWOOD PHARMACEUTICALS INC
IRONWOOD PHARMACEUTICALS drug portfolio — 11 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
100 Summer Street, Boston, MA 02110, US HQ
1998 Founded
262 Employees
Public company Type
IRWD · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Summer Street, Boston, MA 02110, US
- Founded
- 1998
- Employees
- 262
- Programs
- 33
- Drugs
- 11
- Patents
- 45
IRONWOOD PHARMACEUTICALS pipeline
Portfolio lens on 11 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
IRONWOOD PHARMACEUTICALS drug portfolio — 11 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor alpha agonist
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.
-
lesinurad
Musculo-skeletal system (M04)US regulatory status: approved. Molecular target: Solute carrier family 22 member 12.
- Target
- Solute carrier family 22 member 12
- Mechanism
- Solute carrier family 22 member 12 inhibitor
-
linaclotide
Alimentary tract and metabolism (A06)US regulatory status: approved. Molecular target: Guanylyl cyclase C.
- Target
- Guanylyl cyclase C
- Mechanism
- Heat-stable enterotoxin receptor agonist
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.
-
Development asset linked to IRONWOOD PHARMACEUTICALS in public FDA and regional records.